Plasma exchange in critically ill COVID-19 patients
Christian Morath, Markus A. Weigand, Martin Zeier, Claudius Speer, Shilpa Tiwari‐Heckler, Uta Merle
Abstract
The spectrum of coronavirus disease 2019 ranges from asymptomatic infection to respiratory failure and death of patients Severely affected patients may develop a cytokine storm-like clinical syndrome with multi-organ failure and a mortality rate of up to 90% Recently, it has been suggested that plasma exchange (PE) may positively influence this unfavorable course
Topics & Concepts
MedicineCritically illCoronavirus disease 2019 (COVID-19)Intensive care medicine2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Therapeutic plasma exchangeCritical illnessVirologyInternal medicineInfectious disease (medical specialty)OutbreakDiseaseCOVID-19 Clinical Research StudiesHemoglobinopathies and Related DisordersSepsis Diagnosis and Treatment